Tsang JY - Search Results

1

Evaluation of breast-specific marker expression in metastatic breast cancers: Correlation with subtype switch.

Chan R, Leung H, Li J, Poon I, Tsang JY, Ko CW, Wong NM, Tse GM. Chan R, et al. Among authors: tsang jy. Histopathology. 2024 Oct 31. doi: 10.1111/his.15358. Online ahead of print. Histopathology. 2024. PMID: 39478414

2

Biopsy sampling of breast lesions: comparison of core needle- and vacuum-assisted breast biopsies.

Lacambra MD, Lam CC, Mendoza P, Chan SK, Yu AM, Tsang JY, Tan PH, Tse GM. Lacambra MD, et al. Among authors: tsang jy. Breast Cancer Res Treat. 2012 Apr;132(3):917-23. doi: 10.1007/s10549-011-1639-3. Epub 2011 Jun 23. Breast Cancer Res Treat. 2012. PMID: 21698409

3

αB-crystallin is a useful marker for triple negative and basal breast cancers.

Tsang JY, Lai MW, Wong KH, Chan SK, Lam CC, Tsang AK, Yu AM, Tan PH, Tse GM. Tsang JY, et al. Among authors: tsang ak. Histopathology. 2012 Sep;61(3):378-86. doi: 10.1111/j.1365-2559.2012.04234.x. Epub 2012 Mar 28. Histopathology. 2012. PMID: 22463677

4

Relationship between columnar cell changes and low-grade carcinoma in situ of the breast--a cytogenetic study.

Go EM, Tsang JY, Ni YB, Yu AM, Mendoza P, Chan SK, Lam CC, Lui PC, Tan PH, Tse GM. Go EM, et al. Among authors: tsang jy. Hum Pathol. 2012 Nov;43(11):1924-31. doi: 10.1016/j.humpath.2012.02.001. Epub 2012 Apr 27. Hum Pathol. 2012. PMID: 22542249

5

Involvement of α- and β-catenins and E-cadherin in the development of mammary phyllodes tumours.

Tsang JY, Mendoza P, Lam CC, Yu AM, Putti TC, Karim RZ, Scolyer RA, Lee CS, Tan PH, Tse GM. Tsang JY, et al. Histopathology. 2012 Oct;61(4):667-74. doi: 10.1111/j.1365-2559.2012.04271.x. Histopathology. 2012. PMID: 22571452

6

E-cadherin expression in the epithelial components of mammary phyllodes tumors.

Tsang JY, Mendoza P, Putti TC, Karim RZ, Scolyer RA, Lee CS, Pang AL, Tse GM. Tsang JY, et al. Hum Pathol. 2012 Dec;43(12):2117-23. doi: 10.1016/j.humpath.2012.03.028. Epub 2012 Jul 21. Hum Pathol. 2012. PMID: 22820000

7

Keratin expression in breast cancers.

Shao MM, Chan SK, Yu AM, Lam CC, Tsang JY, Lui PC, Law BK, Tan PH, Tse GM. Shao MM, et al. Among authors: tsang jy. Virchows Arch. 2012 Sep;461(3):313-22. doi: 10.1007/s00428-012-1289-9. Epub 2012 Aug 1. Virchows Arch. 2012. PMID: 22851038

8

Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer.

Tsang JY, Huang YH, Luo MH, Ni YB, Chan SK, Lui PC, Yu AM, Tan PH, Tse GM. Tsang JY, et al. Breast Cancer Res Treat. 2012 Nov;136(2):407-17. doi: 10.1007/s10549-012-2271-6. Epub 2012 Sep 30. Breast Cancer Res Treat. 2012. PMID: 23053657

9

Nerve growth factor receptor (NGFR): a potential marker for specific molecular subtypes of breast cancer.

Tsang JY, Wong KH, Lai MW, Lacambra MD, Ko CW, Chan SK, Lam CC, Yu AM, Tan PH, Tse GM. Tsang JY, et al. J Clin Pathol. 2013 Apr;66(4):291-6. doi: 10.1136/jclinpath-2012-201027. Epub 2012 Dec 25. J Clin Pathol. 2013. PMID: 23268325

10

Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas.

Luo MH, Huang YH, Ni YB, Tsang JY, Chan SK, Shao MM, Tse GM. Luo MH, et al. Among authors: tsang jy. Hum Pathol. 2013 Jul;44(7):1241-50. doi: 10.1016/j.humpath.2012.10.009. Epub 2013 Jan 17. Hum Pathol. 2013. PMID: 23332923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters